Robert Vendramelli
Overview
Explore the profile of Robert Vendramelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
175
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Warner B, Vendramelli R, Boese A, Audet J, Tailor N, Meilleur C, et al.
PLoS One
. 2025 Feb;
20(2):e0316952.
PMID: 39908288
Since the emergence of SARS-CoV-2 and the COVID-19 pandemic, a wide range of treatment options have been evaluated in preclinical studies and clinical trials, with several being approved for use...
2.
Chan M, Warner B, Audet J, Barker D, Tailor N, Vendramelli R, et al.
J Virol
. 2024 Jul;
98(8):e0124223.
PMID: 39012096
Importance: There are currently no approved vaccines or therapeutics for Sudan virus, a filovirus which is highly related to Ebola virus and causes similar disease and outbreaks. In this study,...
3.
Warner B, Yates J, Vendramelli R, Truong T, Meilleur C, Chan L, et al.
NPJ Vaccines
. 2024 May;
9(1):90.
PMID: 38782986
The rapid development and deployment of vaccines following the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been estimated to have saved millions of lives. Despite their immense...
4.
Warner B, Chan M, Tailor N, Vendramelli R, Audet J, Meilleur C, et al.
Vaccines (Basel)
. 2024 Apr;
12(4).
PMID: 38675786
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged following an outbreak of unexplained viral illness in China in late 2019. Since then, it has spread globally causing a pandemic that...
5.
LeBlanc K, Lynch J, Layne C, Vendramelli R, Sloan A, Tailor N, et al.
Microbiol Spectr
. 2023 May;
11(3):e0099423.
PMID: 37154717
Coronaviruses (CoVs), including severe acute respiratory syndrome CoV (SARS-CoV), Middle East respiratory syndrome CoV (MERS-CoV), and SARS-CoV-2, produce double-stranded RNA (dsRNA) that activates antiviral pathways such as PKR and OAS/RNase...
6.
Norouzi M, Truong T, Jaenes K, Warner B, Vendramelli R, Tierney K, et al.
Microbiol Spectr
. 2023 Jan;
:e0245722.
PMID: 36719206
Since its emergence in late 2019, the coronavirus disease 2019 (COVID-19) pandemic has caused severe disruption to key aspects of human life globally and highlighted the need for timely, adaptive,...
7.
Tailor N, Warner B, Griffin B, Tierney K, Moffat E, Frost K, et al.
Viruses
. 2023 Jan;
15(1).
PMID: 36680125
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the aetiological agent of coronavirus disease 2019 (COVID-19) that has caused a pandemic with millions of human infections. There continues to be...
8.
Ao Z, Ouyang M, Olukitibi T, Warner B, Vendramelli R, Truong T, et al.
J Virol
. 2022 Sep;
96(18):e0133722.
PMID: 36069551
COVID-19 and influenza are both highly contagious respiratory diseases that have been serious threats to global public health. It is necessary to develop a bivalent vaccine to control these two...
9.
Chan M, Tiwary M, Wu H, Tailor N, Vendramelli R, Audet J, et al.
J Virol
. 2022 Aug;
96(16):e0072822.
PMID: 35924920
The 1918 H1N1 influenza pandemic was among the most severe in history, taking the lives of approximately 50 million people worldwide, and novel prophylactic vaccines are urgently needed to prevent...
10.
Deschambault Y, Lynch J, Warner B, Tierney K, Huynh D, Vendramelli R, et al.
J Virol
. 2022 Apr;
96(9):e0038922.
PMID: 35412347
Increasing cases of SARS-CoV-2 breakthrough infections from immunization with current spike protein-based COVID-19 vaccines highlight the need to develop alternative vaccines using different platforms and/or antigens. In this study, we...